Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
h-ANP for Prevention of AKI in Heart Transplant
NCT02665377Phase 3Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Sep 2016
- Primary completion
- Jan 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of carperitide in acute kidney injury (AKI), sponsored by Sahlgrenska University Hospital. Started Sep 2016; status: completed.
02
Drugs
carperitide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02665377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02665377.